USPTO serial 79220430
LFB
Reviewed by CopyMark Law Group
Reg. 5557831Status 707Registered
- Filing date
- Status date
- Registration date
- Sep 11, 2018
- Examiner
- SEVERSON, JUSTIN
- Law office
- Historical data usage
What this means
This trademark is registered with the USPTO. Monitoring new filings can help you catch lookalike marks early.
Need help with LFB?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
LABORATOIRE FRANCAIS DU FRACTIONNEMENT ET DES BIOTECHNOLOGIES
F-91940 LES ULIS, FR
Other trademarks owned by LABORATOIRE FRANCAIS DU FRACTIONNEMENT ET DES BIOTECHNOLOGIES
LABORATOIRE FRANCAIS DU FRACTIONNEMENT ET DES BIOTECHNOLOGIES
LES ULIS, FR
Other trademarks owned by LABORATOIRE FRANCAIS DU FRACTIONNEMENT ET DES BIOTECHNOLOGIES
LABORATOIRE FRANCAIS DU FRACTIONNEMENT ET DES BIOTECHNOLOGIES
F-91940 LES ULIS, FR
Other trademarks owned by LABORATOIRE FRANCAIS DU FRACTIONNEMENT ET DES BIOTECHNOLOGIES
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
James R. Davis, II
James R. Davis, II Morgan, Lewis & Bockius LLP1111 Pennsylvania Avenue, NWWashington, DC 20004United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical and veterinary products and preparations for the treatment of disorders or diseases in the field of immunology, haemostasis, intensive care; medicines for the treatment of disorders or diseases in the field of immunology, haemostasis, intensive care [ ; diagnostic products for medical and veterinary use for the treatment of disorders or diseases in the field of immunology, haemostasis, intensive care ] | ACTIVE | — |
| 009 | [ Scientific apparatus and instruments, namely, diagnostic apparatus and instruments for calculating and managing drug penetration parameters, for assessing immune deficiency, for laboratory use; downloadable electronic and digital publications, namely, magazines, newsletters, brochures, articles in the field of health; ] downloadable instructional and teaching material, namely, software in the field of health; [ electronic reports featuring results from clinical trials and studies in the field of health; ] recorded software, namely, software for providing medical information in the field of immunology, haemostasis, intensive care, immune deficiency; computer software for educational and commercial activities, namely, software providing information in the field of health; software applications used with medical diagnostic apparatus to calculate and manage immune deficiency or bleeding; computer software for Websites, Intranet and the Internet, namely, software for training and information of patients and health professionals; downloadable computer software applications in the field of health for calculating and managing drug penetration parameters in the human body | ACTIVE | — |
| 010 | [ Medical, veterinary, surgical apparatus and instruments, namely, diagnostic apparatus and instruments in the nature of apparatus for medical diagnostic testing and screening in the field of immunology, haemostasis, intensive care, immune deficiency; apparatus for analysis and diagnosis of disorders or diseases in the field of immunology, haemostasis, intensive care, immune deficiency; medical devices, namely, blood collection kits, disposable cartridge, diagnostic kits consisting primarily of probes, buffers and reagents for use in blood coagulation testing and screening ] | SECTION 71 - CANCELLED | — |
| 035 | [ Retail store services featuring pharmaceutical preparations and products, and medical devices; wholesale retail store services featuring pharmaceutical preparations and products, and medical devices; import and export agencies in the field of pharmaceutical preparations and products, and medical devices; commercial representation, namely, promoting the goods and services of others; sales promotion ] | SECTION 71 - CANCELLED | — |
| 041 | [ Editing and publishing of texts other than advertising texts in the field of health; arranging and providing education, training and instruction, namely, providing classes, seminars, symposiums, congresses, conferences, meetings, educational courses, and workshops in the field of health; organization and conducting of seminars, symposiums, congresses, conferences, meetings, educational courses, and workshops, in the field of health ] | SECTION 71 - CANCELLED | — |
| 042 | [ Scientific and technological services as well as research and design services relating thereto, namely, scientific research, product development, design and testing for new product and engineering in the field of health; industrial analysis and research services in the field of health; scientific research services using protein expression platform technology for research and development of pharmaceuticals; scientific research services using protein expression platform technology for manufacturing protein-based therapeutics; medical and scientific research of recombinant protein platform technologies designed to lead to new human vaccines; conducting scientific studies in the field of immunology, haemostasis, intensive care; research and development of new products for others; scientific research for medical purposes in the field of immunology, haemostasis, intensive care; cellular and molecular biology research; testing of pharmaceutical products; conducting clinical trials for others in the field of immunology, haemostasis, intensive care; engineering; ] advice and assistance in the field of health | ACTIVE | — |
| 044 | [ Medical analysis relating to human blood plasma; ] sampling, collection and preservation of human blood plasma; providing advice and information in the field of health | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by LABORATOIRE FRANCAIS DU FRACTIONNEMENT ET DES BIOTECHNOLOGIES
- Other trademarks owned by LABORATOIRE FRANCAIS DU FRACTIONNEMENT ET DES BIOTECHNOLOGIES
- Other trademarks owned by LABORATOIRE FRANCAIS DU FRACTIONNEMENT ET DES BIOTECHNOLOGIES
- Other trademarks in Class 005
- Other trademarks in Class 009
- Other trademarks in Class 010
- Other trademarks in Class 035
- Other trademarks in Class 041
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named LFB
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 3, 2026 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Jun 12, 2026 | IRIV | IRREGULARITY ON INVALIDATION RECEIVED FROM IB | — |
| Apr 15, 2026 | XXSS | GENERIC MADRID TRANSACTION SENT TO IB | — |
| Apr 15, 2026 | XXCR | GENERIC MADRID TRANSACTION CREATED | — |
| Oct 19, 2025 | INPR | PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| May 20, 2025 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| May 20, 2025 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 20, 2025 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| May 20, 2025 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| May 20, 2025 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Feb 19, 2025 | NA71 | NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED | — |
| Feb 19, 2025 | 71.P | REGISTERED - PARTIAL SEC 71 ACCEPTED | — |
| Feb 18, 2025 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Sep 3, 2024 | ES71 | TEAS SECTION 71 RECEIVED | — |
| May 4, 2024 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Sep 11, 2023 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Apr 15, 2021 | CORN | CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED | — |
| Apr 9, 2021 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Apr 3, 2021 | CRCV | CORRECTION TRANSACTION RECEIVED FROM IB | — |
| Mar 5, 2021 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Mar 15, 2019 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Dec 19, 2018 | XXSS | GENERIC MADRID TRANSACTION SENT TO IB | — |
| Dec 19, 2018 | XXCR | GENERIC MADRID TRANSACTION CREATED | — |
| Dec 11, 2018 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Sep 11, 2018 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jun 26, 2018 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jun 26, 2018 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jun 6, 2018 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| May 21, 2018 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| May 19, 2018 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| May 19, 2018 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| May 16, 2018 | ALIE | ASSIGNED TO LIE | — |
| May 9, 2018 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jan 19, 2018 | RFNT | REFUSAL PROCESSED BY IB | — |
| Dec 17, 2017 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Dec 17, 2017 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Dec 7, 2017 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Dec 6, 2017 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 4, 2017 | DOCK | ASSIGNED TO EXAMINER | — |
| Nov 21, 2017 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Nov 15, 2017 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Nov 9, 2017 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |